All Stories

  1. Advances in Sarcoidosis
  2. From genes to granulomas: the genetic blueprint of sarcoidosis
  3. Genetics in Sarcoidosis and Its Burden as a Multisystem Disease
  4. Sarcoidosis: A State-Of-The-Art Review
  5. Sarcoidosis in the Genomic Era: From Genetic Drivers to Tailored Therapies
  6. Late Breaking Abstract - A multi-ancestry meta-analysis offers new insights into the genetics of sarcoidosis, leveraging data from over 2 million individuals across global biobanks and the MESARGEN Consortium
  7. Mendelian randomization to inform a clinical trial of chitotriosidase inhibition for pulmonary sarcoidosis
  8. Unraveling Genetics in Sarcoidosis: Next Steps
  9. Correction: Clinical progression and genetic pathways in body-first and brain-first Parkinson’s disease
  10. Clinical progression and genetic pathways in body-first and brain-first Parkinson’s disease
  11. Seasonal variation in Swedish sarcoidosis patients with severe hypercalcemia
  12. Ethnicity-specific patterns of epigenetic age acceleration in rheumatoid arthritis
  13. Unraveling genetic mysteries: phenotype-shaping profiles in chronic sarcoidosis
  14. Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis
  15. Deciphering the genetic tapestry: Insights into sarcoidosis across diverse populations with the MESARGEN Consortium
  16. Sarcoidosis shares susceptibility loci with autoimmune disorders and cancers
  17. Big data in sarcoidosis
  18. Precariedad en el empleo periodístico: dimensiones y factores predictores
  19. Corrigendum: Sex differences in the genetics of sarcoidosis across European and African ancestry populations
  20. Sex differences in the genetics of sarcoidosis across European and African ancestry populations
  21. From Karl Wurm and Guy Scadding's staging to 18F-FDG PET/CT scan phenotyping and far beyond: perspective in the evading history of phenotyping in sarcoidosis
  22. Peripheral blood lymphopenia in sarcoidosis associates with HLA-DRB1 alleles but not with lung immune cells and organ involvement
  23. Maternal rheumatoid arthritis and risk of autism in the offspring
  24. Functional link between sarcoidosis-associated gene variants and quantitative levels of bronchoalveolar lavage fluid cell types
  25. Genome-wide association analyses of physical activity and sedentary behavior provide insights into underlying mechanisms and roles in disease prevention
  26. AB0091 INCREASED BIOLOGICAL AGE IN MALE PARTICIPANTS OF SWEDISH AND UK RHEUMATOID ARTHRITIS COHORTS IS NOT LINKED TO DISEASE
  27. AB0034 INVESTIGATING THE ROLE OF ACCELERATED IMMUNESENESCENCE IN THE PATHOGENESIS OF RHEUMATOID ARTHRITIS
  28. Unravelling the genetic basis of sarcoidosis
  29. HLA-DRB1 alleles associate with hypercalcemia in sarcoidosis
  30. Effects of infliximab on lung and circulating natural killer cells, CD56+ T cells and B cells in sarcoidosis
  31. Sex Differences in the Genetics of Sarcoidosis Across European and African Ancestry Populations
  32. Recent advances in sarcoidosis genomics: epigenetics, gene expression, and gene by environment (G × E) interaction studies
  33. Changes in lung immune cells related to clinical outcome during treatment with infliximab for sarcoidosis
  34. High-intensity resistance training in newly diagnosed sarcoidosis- an exploratory study of effects on lung function, muscle strength, fatigue, dyspnea, health-related quality of life and lung immune cells
  35. A Gene–Environment Interaction Between Smoking and Gene polymorphisms Provides a High Risk of Two Subgroups of Sarcoidosis
  36. Renal insufficiency following contrast media administration trial III: Urine flow rate‐guided versus left‐ventricular end‐diastolic pressure‐guided hydration in high‐risk patients for contrast‐induced acute kidney injury. Rationale and design
  37. Obstrucción duodenal por hematoma intramural como complicación de la biopsia endoscópica
  38. Genetic Architecture of Disease Chronicity in Sarcoidosis
  39. A GWAS meta-analysis from 5 population-based cohorts implicates ion channel genes in the pathogenesis of irritable bowel syndrome
  40. Correction: Genome-wide physical activity interactions in adiposity ― A meta-analysis of 200,452 adults
  41. Common variants of T-cells contribute differently to phenotypic variation in sarcoidosis
  42. Genome-wide physical activity interactions in adiposity ― A meta-analysis of 200,452 adults
  43. A meta-analysis of reflux genome-wide association studies in 6750 Northern Europeans from the general population
  44. Approach for Identifying Human Leukocyte Antigen (HLA)-DR Bound Peptides from Scarce Clinical Samples
  45. High-Density Genetic Mapping Identifies New Susceptibility Variants in Sarcoidosis Phenotypes and Shows Genomic-driven Phenotypic Differences
  46. The possible role of chromosome X variability in hypertensive familiarity
  47. T-cell receptor–HLA-DRB1 associations suggest specific antigens in pulmonary sarcoidosis
  48. TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives
  49. Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts
  50. The Role of Adiposity in Cardiometabolic Traits: A Mendelian Randomization Analysis
  51. Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes
  52. Physical Activity Attenuates the Influence of FTO Variants on Obesity Risk: A Meta-Analysis of 218,166 Adults and 19,268 Children
  53. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design
  54. Reply to Letter Regarding Article, "Cystatin C and Contrast-Induced Acute Kidney Injury"
  55. Cystatin C and Contrast-Induced Acute Kidney Injury
  56. Correlations between progression of coronary artery disease and circulating endothelial progenitor cells
  57. Contrast agents and renal cell apoptosis